抗体在抗体与药物结合物的不同作用
Aiko Yamaguchi1, H Charles Manning1,2
1Department of Cancer Systems Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX 77054, USA.
Pharmaceuticals (Basel, Switzerland)
|February 26, 2025
概括
抗体-药物合物 (ADCs) 正通过结合抗体,链接器和有效载荷来彻底改变癌症治疗. 仔细选择抗体点对于最大限度地提高ADC的疗效和最大限度地降低毒性至关重要.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 抗体-药物合物 (ADC) 代表了癌症治疗的重大进步,整合了单克隆抗体,化学链接剂和细胞毒性有效载荷.
- 与传统化疗相比,ADCs通过利用抗体介导的瘤向和有效载荷传递,提供了增强的治疗反应.
研究的目的:
- 审查抗体在ADC的有效性和安全性中所扮演的关键角色.
- 为突出选择适合细胞表面向抗原的ADC发展的关键考虑因素.
主要方法:
- 对抗体-药物结合机制,疗效和安全性概况的文献综述.
- 对瘤特异性,有效载荷循环和固有的作用机制中的抗体功能的分析.
- 讨论ADC开发的挑战,包括目标毒性,非瘤毒性和平台毒性.
主要成果:
- 抗体对于确定ADC瘤特异性,循环半衰期和整体治疗性能至关重要.
- 独特的安全问题,如在点上,瘤外的毒性,源于正常组织中的点表达和瘤透率有限.
- 抗原的选择是影响ADCs临床成功的关键因素.
结论:
- 抗体在ADC中的战略作用需要仔细选择抗原点,以优化疗效和减轻安全风险.
- 解决与抗体吸收和非瘤毒性相关的挑战对于推进ADC治疗至关重要.
更多相关视频
11:58Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting
Published on: March 8, 2018
7.6K
08:53In Vivo Immunofluorescence Localization for Assessment of Therapeutic and Diagnostic Antibody Biodistribution in Cancer Research
Published on: September 16, 2019
8.9K
相关概念视频
Antibody Actions
1.0K
Antibodies, or immunoglobulins, are critical players in the immune system's arsenal against invading pathogens. Produced by B cells and plasma cells, their primary role is to detect and bind to specific antigens, molecules found on the surface of pathogens like bacteria or viruses. Beyond antigen recognition, antibodies perform several vital functions that contribute to immune defense.
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
1.0K
Antibody Structure and Classes
735
Antibodies, also known as immunoglobulins, are produced by B cells in response to foreign substances, such as bacteria and viruses. These proteins are critical for recognizing and neutralizing these substances, protecting the body from potential harm.
The basic structure of an antibody consists of four protein chains: two identical heavy chains and two identical light chains. These chains are held together by disulfide bonds and other non-covalent interactions, forming a Y-shaped structure.
The basic structure of an antibody consists of four protein chains: two identical heavy chains and two identical light chains. These chains are held together by disulfide bonds and other non-covalent interactions, forming a Y-shaped structure.
735
Antibody Structure
58.8K
Overview
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
58.8K
Affinity and Avidity
35.7K
Overview
35.7K
Humoral Immune Responses
71.2K
Overview
71.2K
Cross-reactivity
30.9K
Overview
30.9K
